iScience (Feb 2022)

A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis

  • Maria Tredicine,
  • Chiara Camponeschi,
  • Davide Pirolli,
  • Matteo Lucchini,
  • Mariagrazia Valentini,
  • Maria Concetta Geloso,
  • Massimiliano Mirabella,
  • Marco Fidaleo,
  • Benedetta Righino,
  • Camilla Moliterni,
  • Ezio Giorda,
  • Mario Rende,
  • Maria Cristina De Rosa,
  • Maria Foti,
  • Gabriela Constantin,
  • Francesco Ria,
  • Gabriele Di Sante

Journal volume & issue
Vol. 25, no. 2
p. 103763

Abstract

Read online

Summary: In the pathogenesis of autoimmune disorders, the modulation of leukocytes′ trafficking plays a central role, still poorly understood. Here, we focused on the effect of TLR2 ligands in trafficking of T helper cells through reshuffling of CD44 isoforms repertoire. Concurrently, strain background and TLR2 haplotype affected Wnt/β-catenin signaling pathway and expression of splicing factors. During EAE, mCD44v9-v10 was specifically enriched in the forebrain and showed an increased ability to bind stably to osteopontin. Similarly, we observed that hCD44v7 was highly enriched in cells of cerebrospinal fluid from MS patients with active lesions. Moreover, TLRs engagement modulated the composition of CD44 variants also in human T helper cells, supporting the hypothesis that pathogens or commensals, through TLRs, in turn modulate the repertoire of CD44 isoforms, thereby controlling the distribution of lesions in the CNS. The interference with this mechanism(s) represents a potential tool for prevention and treatment of autoimmune relapses and exacerbations.

Keywords